有晶状体眼后房型人工晶状体植入术治疗高度近视的临床研究

目的 探讨有晶状体眼后房型人工晶状体(ICL)植入术治疗高度近视的临床效果.方法 对12例24眼接受ICL植入术的患者资料进行总结和分析,比较其手术前后最佳矫正视力、眼压及透明晶状体性状的改变.结果 12例24眼术后最佳矫正视力均达到或超过术前最佳矫正视力,改善了高度近视患者的视功能状况,术前眼压(14.26±2.13)mm Hg(1 mmHg=0.133 kPa),术后1年眼压(14.79±2.77)mm Hg(P＞0.05),术后眼压稳定,术后ICL与透明晶状体存在裂隙,随访期间未见并发性白内障、慢性色素膜炎等并发症.结论 ICL植入术治疗高度近视手术效果确切,预测性好,安全性高.

Clinical research of phakic posterior chamber intraocular lens implantation for high myopia

Objective To investigate the clinical efficacy and safety of phakic posterior chamber intraocular lens (ICL) implantation for high myopia. Methods Twenty-four eyes of 12 patients with high myopia were treated with ICL implantation. The best corrected visual acuity, intraocular pressure and lens changes shape between post-operative and pre-operative were compared. Results Successful implantations were done in all patients. All eyes had a significant increase in uncorrected visual acuity. Exactly improved visual function in patients with high myopia status. The intraocular pressure was ( 14.26 ± 2.13) mm Hg(1 mm Hg = 0.133 kPa) of pre-operative , and was ( 14.79 ± 2.77) mm Hg at 1 year after post-operative, the intraocular pressure was stability after the operation. UBM showed that there was a certain gap between ICL and the lens. During the follow-up period,no complications such as cataract,chronic uveal infusion were found. Conclusion Phakic posterior chamber ICL implantation is effective,safe and reliable method for the correction of high myopia.